Inicio › Cáncer de seno › California › Baldwin Park
Ensayos clínicos de Cáncer de seno en Baldwin Park, CA
44 estudios para Cáncer de seno buscan participantes en centros de Baldwin Park y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ReclutandoFase 3
- City of Hope National Medical Center, Duarte · A 4 mi de distancia
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
ReclutandoFase 2
- City of Hope - Duarte Cancer Center, Duarte · A 4 mi de distancia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ReclutandoFase 3
- City of Hope National Medical, Duarte · A 4 mi de distancia
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- City of Hope, Duarte · A 4 mi de distancia
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
ReclutandoFase 2
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ReclutandoFase 1
- City of Hope Comprehensive Cancer Center, Duarte · A 4 mi de distancia
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ReclutandoFase 1
- Research Site, Duarte · A 4 mi de distancia
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ReclutandoFase 2
- City of Hope, Duarte · A 4 mi de distancia
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- City of Hope, Duarte · A 4 mi de distancia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ReclutandoFase 3
- City of Hope, Duarte · A 4 mi de distancia
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
ReclutandoFase 2
- City of Hope, Duarte · A 4 mi de distancia
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
ReclutandoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · A 4 mi de distancia
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ReclutandoFase 1/2
- City of Hope, Duarte · A 4 mi de distancia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- City of Hope National Medical Center, Duarte · A 4 mi de distancia
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
ReclutandoFase 1/2
- City of Hope - Duarte, Duarte · A 4 mi de distancia
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ReclutandoFase 1
- City of Hope, Duarte · A 4 mi de distancia
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
ReclutandoFase 3
- Research Site, Duarte · A 4 mi de distancia
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
ReclutandoFase 1/2
- City of Hope, Duarte · A 4 mi de distancia
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
ReclutandoFase 1/2
- City of Hope, Duarte · A 4 mi de distancia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- City of Hope Medical Center, Duarte · A 4 mi de distancia
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
ReclutandoFase 1
- City of Hope, Duarte · A 4 mi de distancia
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ReclutandoFase 2
- City of Hope--Duarte, Duarte · A 4 mi de distancia
A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
Reclutando
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ReclutandoFase 3
- City of Hope - Duarte Cancer Center, Duarte · A 4 mi de distancia
E-Mindfulness Approaches for Living After Breast Cancer
ReclutandoFase 3
- Kaiser Permanente-Baldwin Park, Baldwin Park
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
ReclutandoFase 1
- City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte · A 4 mi de distancia
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
ReclutandoFase 2
- City of Hope Comprehensive Cancer Center, Duarte · A 4 mi de distancia
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
ReclutandoFase 4
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
ReclutandoFase 2
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
ReclutandoFase 3
- City of Hope Medical Center, Duarte · A 4 mi de distancia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ReclutandoFase 2
- City of Hope, Duarte · A 4 mi de distancia
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Reclutando
- Beckman Research Institute of City of Hope, Duarte · A 4 mi de distancia
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
ReclutandoFase 1
- City of Hope, Duarte · A 4 mi de distancia
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- City of Hope, Duarte · A 4 mi de distancia
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer
ReclutandoSe aceptan voluntarios sanos
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer
ReclutandoFase 2
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
ReclutandoFase 2
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
ReclutandoFase 2
- City of Hope Medical Center, Duarte · A 4 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Duarte · A 4 mi de distancia
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
ReclutandoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · A 4 mi de distancia
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
ReclutandoFase 2
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
ReclutandoFase 1
- City of Hope Medical Center, Duarte · A 4 mi de distancia
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Baldwin Park
- Leucemia mielógena aguda40 estudios
- Cáncer del colon y del recto37 estudios
- Cáncer de pulmón de células no pequeñas36 estudios
- Cáncer (todos los tipos)34 estudios
- Cáncer de próstata30 estudios
- Cáncer metastásico30 estudios
- Síndromes mielodisplásicos26 estudios
- Cáncer de ovario25 estudios
- Cáncer de pulmón24 estudios
- Mieloma múltiple23 estudios
- Cáncer de estómago22 estudios
- Leucemia linfoblástica aguda21 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.